FOXO4-DRI
Reviewed by Fat Man in the Arena · Updated March 2026
Key Takeaway
FOXO4-DRI is a senolytic peptide designed to selectively destroy senescent (zombie) cells that accumulate with aging and contribute to chronic inflammation.
How it works
Disrupts the interaction between FOXO4 and p53 proteins in senescent cells, triggering apoptosis (cell death) specifically in damaged, non-functional cells.
Benefits
- Selective senescent cell clearance
- Potential tissue rejuvenation
- Reduced age-related inflammation
Side effects
- Very limited human data
- Theoretical concern about destroying needed senescent cells
Dosing protocol
Typical Dose
Experimental — no established human dose
Frequency
Varies
Highly experimental. Very expensive. Limited availability.
Related peptides
Looking for weight loss peptides? See our complete guide to the best peptides for weight loss or compare semaglutide vs tirzepatide.
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.